LeMaitre Vascular ROA 2007-2020 | LMAT

Current and historical return on assets (ROA) values for LeMaitre Vascular (LMAT) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. LeMaitre Vascular ROA for the three months ending June 30, 2020 was 8.25%.
LeMaitre Vascular ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2020-06-30 $0.02B $0.26B 8.51%
2020-03-31 $0.02B $0.19B 10.20%
2019-12-31 $0.02B $0.19B 11.16%
2019-09-30 $0.02B $0.17B 12.38%
2019-06-30 $0.02B $0.16B 12.26%
2019-03-31 $0.02B $0.16B 15.49%
2018-12-31 $0.02B $0.15B 16.34%
2018-09-30 $0.02B $0.14B 15.67%
2018-06-30 $0.02B $0.14B 17.15%
2018-03-31 $0.02B $0.13B 14.75%
2017-12-31 $0.02B $0.13B 14.59%
2017-09-30 $0.02B $0.12B 14.48%
2017-06-30 $0.01B $0.11B 13.27%
2017-03-31 $0.01B $0.11B 11.82%
2016-12-31 $0.01B $0.10B 11.22%
2016-09-30 $0.01B $0.10B 11.55%
2016-06-30 $0.01B $0.10B 10.90%
2016-03-31 $0.01B $0.09B 10.17%
2015-12-31 $0.01B $0.09B 9.38%
2015-09-30 $0.01B $0.09B 8.46%
2015-06-30 $0.01B $0.08B 7.32%
2015-03-31 $0.01B $0.08B 6.13%
2014-12-31 $0.00B $0.08B 5.08%
2014-09-30 $0.00B $0.08B 3.95%
2014-06-30 $0.00B $0.08B 4.18%
2014-03-31 $0.00B $0.07B 4.44%
2013-12-31 $0.00B $0.07B 6.06%
2013-09-30 $0.00B $0.07B 6.23%
2013-06-30 $0.00B $0.06B 6.37%
2013-03-31 $0.00B $0.06B 6.48%
2012-12-31 $0.00B $0.06B 4.94%
2012-09-30 $0.00B $0.06B 3.33%
2012-06-30 $0.00B $0.06B 3.31%
2012-03-31 $0.00B $0.06B 3.28%
2011-12-31 $0.00B $0.06B 3.25%
2011-09-30 $0.00B $0.06B 6.43%
2011-06-30 $0.01B $0.06B 8.10%
2011-03-31 $0.01B $0.06B 9.88%
2010-12-31 $0.01B $0.06B 11.72%
2010-09-30 $0.01B $0.06B 10.30%
2010-06-30 $0.01B $0.06B 8.77%
2010-03-31 $0.00B $0.06B 7.14%
2009-12-31 $0.00B $0.06B 1.83%
2009-09-30 $0.00B $0.06B 0.00%
2009-06-30 $-0.00B $0.05B -1.88%
2009-03-31 $-0.00B $0.05B -5.58%
2008-12-31 $-0.00B $0.05B -7.24%
2008-09-30 $-0.01B $0.05B -8.77%
2008-06-30 $-0.01B $0.06B -10.39%
2008-03-31 $-0.01B $0.06B -8.66%
2007-12-31 $-0.00B $0.06B -5.22%
2007-06-30 $-0.00B $0.06B -4.73%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.595B $0.117B
LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $176.761B 33.20
Medtronic (MDT) Ireland $129.154B 20.98
Stryker (SYK) United States $70.955B 27.51
Boston Scientific (BSX) United States $51.986B 30.70
Lonza Group Ag (LZAGY) Switzerland $46.178B 0.00
Baxter (BAX) United States $41.045B 25.10
Terumo (TRUMY) Japan $29.530B 37.75
ResMed (RMD) United States $29.334B 46.29
EssilorLuxottica Societe Anonyme (ESLOY) France $28.492B 0.00
Zimmer Biomet Holdings (ZBH) United States $26.965B 22.45
Sunny Optical Technology (SNPTF) China $20.566B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $17.585B 0.00
Bio-Rad Laboratories (BIO) United States $15.620B 70.72
Insulet (PODD) United States $13.019B 1289.81
Quidel (QDEL) United States $12.525B 66.35
Shandong Weigao Medical Polymer (SHWGF) China $11.849B 0.00
DiaSorin S.p.A (DSRLF) Italy $11.312B 0.00
GN STORE NORD (GNNDY) Denmark $8.157B 41.58
Perrigo (PRGO) Ireland $7.514B 13.44
William Demant Holdings (WILYY) Denmark $7.457B 0.00
Canopy Growth (CGC) Canada $7.165B 0.00
Hill-Rom Holdings (HRC) United States $6.311B 15.66
GW Pharmaceuticals (GWPH) United Kingdom $4.203B 0.00
Neogen (NEOG) United States $4.135B 69.10
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.995B 0.00
Haemonetics (HAE) United States $3.842B 25.80
ICU Medical (ICUI) United States $3.834B 27.97
Envista Holdings (NVST) United States $3.641B 24.83
Abcam (ABCZY) $3.406B 0.00
Agios Pharmaceuticals (AGIO) United States $3.048B 0.00
NuVasive (NUVA) United States $2.754B 38.38
National Vision Holdings (EYE) United States $2.703B 46.76
TG Therapeutics (TGTX) United States $2.246B 0.00
AtriCure (ATRC) United States $1.854B 0.00
DFB Healthcare Acquisitions (AHCO) United States $1.706B 157.08
MacroGenics (MGNX) United States $1.438B 0.00
Aphria (APHA) Canada $1.408B 0.00
NanoString Technologies (NSTG) United States $1.349B 0.00
Aurora Cannabis (ACB) Canada $1.239B 0.00
Cerus (CERS) United States $1.225B 0.00
OraSure Technologies (OSUR) United States $1.197B 241.13
Vapotherm (VAPO) United States $1.124B 0.00
Meridian Bioscience (VIVO) United States $1.091B 41.06
Cardiovascular Systems (CSII) United States $1.086B 0.00
PetIQ (PETQ) United States $1.062B 30.68
InMode (INMD) Israel $1.053B 22.24
Owens & Minor (OMI) United States $1.047B 23.74
Phibro Animal Health (PAHC) United States $0.951B 18.96
Quanterix (QTRX) United States $0.934B 0.00
Omeros (OMER) United States $0.714B 0.00
BioLife Solutions (BLFS) United States $0.670B 190.82
Eagle Pharmaceuticals (EGRX) United States $0.659B 47.18
Surmodics (SRDX) United States $0.640B 77.15
VAREX IMAGING (VREX) United States $0.636B 15.80
Zynex (ZYXI) United States $0.626B 54.70
Lantheus Holdings (LNTH) United States $0.503B 11.72
Viemed Healthcare (VMD) United States $0.434B 38.48
Cytosorbents (CTSO) United States $0.341B 0.00
HEXO (HEXO) $0.338B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.331B 0.00
Utah Medical Products (UTMD) United States $0.295B 25.33
InfuSystems Holdings (INFU) United States $0.256B 141.56
Organigram Holdings (OGI) Canada $0.228B 0.00
Female Health (VERU) United States $0.214B 0.00
Chimerix (CMRX) United States $0.207B 0.00
Exagen (XGN) United States $0.177B 0.00
Bovie Medical (APYX) United States $0.168B 0.00
Fonar (FONR) United States $0.161B 14.24
Surface Oncology (SURF) United States $0.159B 0.00
Wound Management Technologies (SMTI) United States $0.149B 0.00
Liberty Health Sciences (LHSIF) Canada $0.128B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.126B 0.00
Rockwell Medical (RMTI) United States $0.124B 0.00
Chembio Diagnostics (CEMI) United States $0.119B 0.00
Capricor Therapeutics (CAPR) United States $0.115B 0.00
Evolus (EOLS) United States $0.106B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.093B 0.00
MTech Acquisition (KERN) United States $0.089B 0.00
Nephros (NEPH) United States $0.076B 0.00
United-Guardian (UG) United States $0.072B 16.78
Brainsway (BWAY) Israel $0.066B 0.00
Trinity Biotech (TRIB) Ireland $0.059B 0.00
ImmuCell (ICCC) United States $0.040B 0.00
GUARDION HEALTH (GHSI) United States $0.034B 0.00
Akers Biosciences Inc (AKER) United States $0.031B 0.00
FSD PHARMA INC (HUGE) Canada $0.028B 0.00
NF Energy Saving (BIMI) China $0.021B 0.00
Myomo (MYO) United States $0.011B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.010B 0.00
Senestech (SNES) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00